Results 191 to 200 of about 439,387 (353)

Mammary Sarcoma - Not Otherwise Specified: A Case Report

Middle East Journal of Cancer, 2016
Mammary sarcomas are a heterogeneous group of malignant neoplasms that arise from the mammary stroma. Primary sarcomas of the breast are extremely rare and comprise less than 0.1% of all malignant tumors of the breast. We present the case of a 56-year-
Nazima Haider, Sohaila Fatima
doaj  

Gene Regulatory Network Analysis for Triple-Negative Breast Neoplasms by Using Gene Expression Data. [PDF]

J Breast Cancer, 2017
Jung HC, Kim SH, Lee JH, Kim JH, Han SW.
europepmc   +1 more source

Intensity Modulated Radiotherapy of Two Simultaneous Neoplasms - Cervical Carcinoma and Breast Carcinoma: A Case Report with a Review of the Literature

, 2021
Lena Marinova, В. Г. Петров, Vaska Vassileva   +2 more
openalex   +2 more sources

Olaparib synergy screen reveals Exemestane induces replication stress in triple‐negative breast cancer

Molecular Oncology, EarlyView.
Screening 166 FDA‐approved anticancer drugs identifies the aromatase inhibitor Exemestane as a synergistic partner of PARP inhibitor Olaparib in BRCA‐proficient triple‐negative breast cancer. Exemestane induces ROS‐mediated replication stress, enhancing DNA damage and apoptosis alongside Olaparib.
Nur Aininie Yusoh, Liping Su, Suet Lin Chia, Xiaohe Tian, Haslina Ahmad, Martin R. Gill   +5 more
wiley   +1 more source

Induction of mammary neoplasms in the ACI rat by 430-keV neutrons, X-rays, and diethylstilbestrol [PDF]

, 1982
Chmelevsky, D., Holtzman, S., Kellerer, Albrecht M., Shellabarger, C. J., Stone, J. P.   +4 more
core   +1 more source

RKIP overexpression reduces lung adenocarcinoma aggressiveness and sensitizes cells to EGFR‐targeted therapies

Molecular Oncology, EarlyView.
RKIP, a metastasis suppressor protein, modulates key oncogenic pathways in lung adenocarcinoma. In silico analyses linked low RKIP expression to poor survival. Functional studies revealed RKIP overexpression reduces tumor aggressiveness and enhances sensitivity to EGFR‐targeted therapies, while its loss promotes resistance.
Ana Raquel‐Cunha, Joana Pinheiro, Rui F. Marques, Patrícia Fontão, Diana Cardoso‐Carneiro, Adriana Mendes, Izabela N. F. Gomes, Ana Carolina Laus, Renato J. da Silva‐Oliveira, Rui Manuel Reis, Olga Martinho   +10 more
wiley   +1 more source

The significance of ductoscopy of mammary ducts in the diagnostics of breast neoplasms. [PDF]

Wideochir Inne Tech Maloinwazyjne, 2015
Zielinski J, Jaworski R, Irga-Jaworska N, Haponiuk I, Jaskiewicz J.   +4 more
europepmc   +1 more source

Enzymatic activity of blood serum, abzyme activity of IgG and IgA, free serum DNA and the formation of extracellular traps by neutrophils in patients with breast neoplasms

, 2017
С. В. Жерулик, N.G. Lud, С. В. Генералов, E. S. Orlova, И. И. Генералов   +4 more
openalex   +2 more sources

Nicotinamide N‐methyltransferase promotes drug resistance in lung cancer, as revealed by nascent proteomic profiling

Molecular Oncology, EarlyView.
AZD9291 has shown promise in targeted cancer therapy but is limited by resistance. In this study, we employed metabolic labeling and LC–MS/MS to profile time‐resolved nascent protein perturbations, allowing dynamic tracking of drug‐responsive proteins. We demonstrated that increased NNMT expression is associated with drug resistance, highlighting NNMT ...
Zhanwu Hou, Zhen Wang, Fei Yang, Xiao Han, Lei Li, Huadong Liu   +5 more
wiley   +1 more source

The Correlation of Plasma 25-Hydroxyvitamin D Deficiency With Risk of Breast Neoplasms: A Systematic Review. [PDF]

Iran J Cancer Prev, 2016
Shekarriz-Foumani R, Khodaie F.
europepmc   +1 more source